Houston, TX, United States of America

Pomila Singh

This inventor holds 8 USPTO granted patents and 2 published patent applications. Top assignee: The University of Texas System. Active years: 1998-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pomila Singh. Retrieved from https://idiyas.com/inventor/pomila-singh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 100.0

Average Co-Inventor Count = 1.5

ph-index = 3

Forward Citations = 139(Granted Patents)


Location History:

  • Galveston, TX (US) (1998 - 2017)
  • Houston, TX (US) (2010 - 2019)

Company Filing History:


Years Active: 1998-2019

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Pomila Singh: Innovator in Cancer Treatment

Introduction

Pomila Singh is a prominent inventor based in Houston, TX (US). She has made significant contributions to the field of immunotherapy, particularly in the treatment of various cancers. With a total of 8 patents, her work focuses on innovative methods to diagnose and treat tumors that are dependent on progastrin.

Latest Patents

One of her latest patents is titled "Immunogenic compositions comprising progastrin and uses thereof." This invention is directed towards immunotherapeutic methods aimed at treating tumors or cancers that produce progastrin ectopically or rely on progastrin for their growth. The patent discloses immunogenic compositions that include agents targeting progastrin, the progastrin receptor, annexin II, or a combination of these. Such compositions can be administered alongside chemotherapy or to individuals who have previously undergone chemotherapy or radiation therapy. The cancers that may be treated using this composition include, but are not limited to, colon cancer, breast cancer, lung cancer, and pancreatic cancer.

Another significant patent is focused on the "Diagnosis of benign and cancerous growths by measuring circulating tumor stem cells and serum AnnexinA2." This method provides a way to diagnose or prognose metastatic cancer by detecting specific circulating tumor stem cells in the subject's blood or plasma. It also offers a means to distinguish between early-stage primary cancer and advanced-stage metastatic cancer, as well as to identify benign, pre-cancerous, or cancerous tumors.

Career Highlights

Pomila Singh is affiliated with the University of Texas System, where she continues her research and development in cancer treatment. Her innovative approaches have garnered attention in the medical community, contributing to advancements in cancer diagnostics and therapeutics.

Collaborations

Throughout her career, Pomila has collaborated with notable colleagues, including Thomas G Wood and Gurpreet Singh. These collaborations have further enhanced her research and the impact of her inventions.

Conclusion

Pomila Singh is a trailblazer in the field of cancer treatment, with a focus on immunotherapy and innovative diagnostic methods. Her contributions are paving the way for new approaches to combat cancer, making her a significant figure in the realm of medical inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…